• All Categories
  • Analytics
  • Digital
  • Discovery and Development
  • Manufacturing
  • Laboratory Automation
  • Press Releases
bit.bio chooses Automata for automating an aspect of its production of iPSC derived human cells bit.bio chooses Automata for automating an aspect of its production of iPSC derived human cells
bit.bio chooses Automata for automating an aspect of its production of iPSC derived human cells

26th January 2023, London UK – Automata, a leading robotics and automation company powering life sciences labs, today announced it is partnering with bit.bio, to automate a key aspect of the manufacturing process of their iPSC (induced pluripotent stem cell)-derived human cell products.

Jan 26, 2023 Press Releases
Evotec Announces Agreement with Janssen to Develop Immune-Based TherapiesEvotec Announces Agreement with Janssen to Develop Immune-Based Therapies
Evotec Announces Agreement with Janssen to Develop Immune-Based Therapies

HAMBURG, GERMANY / ACCESSWIRE / January 26, 2023 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) announced today that the Company has entered into a strategic collaboration and licence agreement with Janssen Biotech, Inc. ("Janssen"), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Jan 26, 2023 Press Releases
Catalent Completes Commercial-Scale Plasmid DNA Manufacturing Facility in Gosselies, BelgiumCatalent Completes Commercial-Scale Plasmid DNA Manufacturing Facility in Gosselies, Belgium
Catalent Completes Commercial-Scale Plasmid DNA Manufacturing Facility in Gosselies, Belgium

SOMERSET, N.J. – January 26, 2023 – Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the opening of a new commercial-scale plasmid DNA (pDNA) manufacturing facility at its European center of excellence for cell therapies, in Gosselies, Belgium.

Jan 26, 2023 Press Releases
Thermo Fisher and AstraZeneca partner to Develop Solid Tissue, Blood-Based Companion Diagnostic TestThermo Fisher and AstraZeneca partner to Develop Solid Tissue, Blood-Based Companion Diagnostic Test
Thermo Fisher and AstraZeneca partner to Develop Solid Tissue, Blood-Based Companion Diagnostic Test

24 January -- CARLSBAD, Calif.--(BUSINESS WIRE)-- As part of a global, multiyear agreement, Thermo Fisher Scientific today announced it is working with AstraZeneca to develop a solid tissue and blood-based companion diagnostic (CDx) test for Tagrisso (osimertinib).

Jan 25, 2023 Press Releases
Thermo Fisher Scientific Launches CE-IVD Marked Assay to Detect Treatment-Resistant Strains of HIV-1Thermo Fisher Scientific Launches CE-IVD Marked Assay to Detect Treatment-Resistant Strains of HIV-1
Thermo Fisher Scientific Launches CE-IVD Marked Assay to Detect Treatment-Resistant Strains of HIV-1

CARLSBAD, Calif.--(BUSINESS WIRE)-- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, a Sanger sequencing-based assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that may resist common antiretroviral therapeutics.

Jan 25, 2023 Press Releases
rms Company Scales Medical Device Production with Addition of 3D Systems’ DMP Flex 350 Dual rms Company Scales Medical Device Production with Addition of 3D Systems’ DMP Flex 350 Dual
rms Company Scales Medical Device Production with Addition of 3D Systems’ DMP Flex 350 Dual

ROCK HILL, South Carolina, January 19, 2023 – Today, 3D Systems (NYSE:DDD) announced rms Company, one of the largest contract manufacturers of high-quality, tight-tolerance medical devices in the world, has added the DMP Flex 350 Dual to its production workflow. rms has more than 30 3D Systems’ DMP 3D printers in its additive manufacturing facility enabling the company to provide a complete Powder to Package capability to medical device OEMs.

Jan 24, 2023 Press Releases
Ubiquigent and University of Glasgow to collaborate on drug discoveryUbiquigent and University of Glasgow to collaborate on drug discovery
Ubiquigent and University of Glasgow to collaborate on drug discovery

Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, is supporting a Master’s student at the University of Glasgow (UoG) to undertake a research project on USP30, a DUB implicated in neruodegenerative, renal, and cardiovascular diseases.

Jan 24, 2023 Press Releases
InDevR raises $9 million in series B financing and partners with bioMérieuxInDevR raises $9 million in series B financing and partners with bioMérieux
InDevR raises $9 million in series B financing and partners with bioMérieux

Boulder, CO, 17th of January, 2023 – InDevR, Inc., a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has raised $9 million in series B financing. Adjuvant Capital has invested $4 million, and bioMérieux – a worldwide leader in in vitro diagnostics and microbiological quality control solutions for the food and pharmaceutical industries – $5 million.

Jan 23, 2023 Press Releases
Benchling appoints first EMEA general manager amidst rapid European growthBenchling appoints first EMEA general manager amidst rapid European growth
Benchling appoints first EMEA general manager amidst rapid European growth

ZURICH, January 19, 2023 – Benchling, the R&D Cloud powering the biotechnology industry, today announced the appointment of its first general manager in EMEA, Bob Burke. The hire comes at a time when Benchling is accelerating growth in the region — the company more than doubled customer count from one year ago, grew its regional team to over 120 employees, and expanded with enterprise customers including Novozymes, Syngenta, and more.

Jan 19, 2023 Press Releases
Bruker Announces Acquisition of ACQUIFER Imaging GmbHBruker Announces Acquisition of ACQUIFER Imaging GmbH
Bruker Announces Acquisition of ACQUIFER Imaging GmbH

HEIDELBERG, Germany – January 5, 2023 – Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy.

Jan 19, 2023 Press Releases
Cambrex Acquires Snapdragon Chemistry, a Leader in Continuous Flow API Development ServicesCambrex Acquires Snapdragon Chemistry, a Leader in Continuous Flow API Development Services
Cambrex Acquires Snapdragon Chemistry, a Leader in Continuous Flow API Development Services

East Rutherford, NJ – January 18, 2023 – Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has completed its acquisition of Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers.

Jan 19, 2023 Press Releases
Agilent Invests $725m to Expand Manufacturing Capacity to Produce Nucleic Acid-Based TherapeuticsAgilent Invests $725m to Expand Manufacturing Capacity to Produce Nucleic Acid-Based Therapeutics
Agilent Invests $725m to Expand Manufacturing Capacity to Produce Nucleic Acid-Based Therapeutics

SANTA CLARA, Calif., January 09, 2023 -- Agilent Technologies Inc. (NYSE: A) today announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’s high-quality active pharmaceutical ingredients (API).

Jan 19, 2023 Press Releases